Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

22nd Century Group Appoints James A. Mish to Its Board of Directors


22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the appointment of James A. Mish to its Board of Directors...

Mentions: Nasdaq 22nd Century Group, Inc. Board